ArticleOncoimmunology2023

Novel Fab-peptide-HLA-I fusion proteins for redirecting pre-existing anti-CMV T cell immunity to selective eliminate carcinoma cells.

Isabel Britsch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.